skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 533,834  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Correction: Assessing development assistance for child survival between 2000 and 2014: A multi-sectoral perspective
Material Type:
Article
Add to My Research

Correction: Assessing development assistance for child survival between 2000 and 2014: A multi-sectoral perspective

PloS one, 2018-01, Vol.13 (1), p.e0192309-e0192309 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Lu et al 2018 Lu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0192309 ;PMID: 29381752

Full text available

2
Correction: A Twin Protection Effect? Explaining Twin Survival Advantages with a Two-Process Mortality Model
Material Type:
Article
Add to My Research

Correction: A Twin Protection Effect? Explaining Twin Survival Advantages with a Two-Process Mortality Model

PloS one, 2017-02, Vol.12 (2), p.e0171794-e0171794 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Sharrow, Anderson. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Sharrow, Anderson 2017 Sharrow, Anderson ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0171794 ;PMID: 28152091

Full text available

3
Risdiplam in Type 1 Spinal Muscular Atrophy
Material Type:
Article
Add to My Research

Risdiplam in Type 1 Spinal Muscular Atrophy

The New England journal of medicine, 2021-03, Vol.384 (10), p.915-923 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2009965 ;PMID: 33626251

Full text available

4
Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases
Material Type:
Article
Add to My Research

Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases

Cancer communications (London, England), 2021-01, Vol.41 (1), p.37-50 [Peer Reviewed Journal]

2020 The Authors. published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center ;2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1002/cac2.12113 ;PMID: 33270990

Full text available

5
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
Material Type:
Article
Add to My Research

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

The Lancet (British edition), 2019-06, Vol.393 (10189), p.2404-2415 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30723-8 ;PMID: 31079938

Full text available

6
A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein
Material Type:
Article
Add to My Research

A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein

Scientific reports, 2016-08, Vol.6 (1), p.30778-30778, Article 30778 [Peer Reviewed Journal]

Copyright Nature Publishing Group Aug 2016 ;Copyright © 2016, The Author(s) 2016 The Author(s) ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/srep30778 ;PMID: 27481219

Full text available

7
Sinonasal malignancies: A population-based analysis of site-specific incidence and survival
Material Type:
Article
Add to My Research

Sinonasal malignancies: A population-based analysis of site-specific incidence and survival

The Laryngoscope, 2015-11, Vol.125 (11), p.2491-2497 [Peer Reviewed Journal]

2015 The American Laryngological, Rhinological and Otological Society, Inc. ;ISSN: 0023-852X ;EISSN: 1531-4995 ;DOI: 10.1002/lary.25465 ;PMID: 26228792

Full text available

8
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Material Type:
Article
Add to My Research

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Nature (London), 2020-01, Vol.577 (7791), p.561-565 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 23, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1914-8 ;PMID: 31942071

Full text available

9
RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns
Material Type:
Article
Add to My Research

RNA-sequencing of a mouse-model of spinal muscular atrophy reveals tissue-wide changes in splicing of U12-dependent introns

Nucleic acids research, 2017-01, Vol.45 (1), p.395-416 [Peer Reviewed Journal]

The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. ;The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research. 2017 ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkw731 ;PMID: 27557711

Full text available

10
Survival and Neurodevelopmental Outcomes among Periviable Infants
Material Type:
Article
Add to My Research

Survival and Neurodevelopmental Outcomes among Periviable Infants

The New England journal of medicine, 2017-02, Vol.376 (7), p.617-628 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1605566 ;PMID: 28199816

Full text available

11
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

The Lancet (British edition), 2020-01, Vol.395 (10218), p.132-141 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32956-3 ;PMID: 31836199

Full text available

12
Extent of lymph node dissection at nephrectomy affects cancer‐specific survival and metastatic progression in specific sub‐categories of patients with renal cell carcinoma (RCC)
Material Type:
Article
Add to My Research

Extent of lymph node dissection at nephrectomy affects cancer‐specific survival and metastatic progression in specific sub‐categories of patients with renal cell carcinoma (RCC)

BJU international, 2014-08, Vol.114 (2), p.210-215 [Peer Reviewed Journal]

2013 The Authors. BJU International © 2013 BJU International ;2015 INIST-CNRS ;2013 The Authors. BJU International © 2013 BJU International. ;ISSN: 1464-4096 ;EISSN: 1464-410X ;DOI: 10.1111/bju.12508 ;PMID: 24854206 ;CODEN: BJINFO

Full text available

13
Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy
Material Type:
Article
Add to My Research

Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy

British journal of cancer, 2013-09, Vol.109 (5), p.1093-1099 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Nature Publishing Group Sep 3, 2013 ;Copyright © 2013 Cancer Research UK 2013 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2013.458 ;PMID: 23928661 ;CODEN: BJCAAI

Full text available

14
Prognostic modeling of predictive maintenance with survival analysis for mobile work equipment
Material Type:
Article
Add to My Research

Prognostic modeling of predictive maintenance with survival analysis for mobile work equipment

Scientific reports, 2022-05, Vol.12 (1), p.8529-8529, Article 8529 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-022-12572-z ;PMID: 35595821

Full text available

15
Prolonged Survival Following Pig‐to‐Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade
Material Type:
Article
Add to My Research

Prolonged Survival Following Pig‐to‐Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade

American journal of transplantation, 2017-08, Vol.17 (8), p.2178-2185 [Peer Reviewed Journal]

2017 The American Society of Transplantation and the American Society of Transplant Surgeons ;2017 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.14341 ;PMID: 28489305

Full text available

16
New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
Material Type:
Article
Add to My Research

New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3297 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the author. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21093297 ;PMID: 32392694

Full text available

17
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Material Type:
Article
Add to My Research

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

The New England journal of medicine, 2010-09, Vol.363 (14), p.1324-1334 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2010 Massachusetts Medical Society. 2010 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0911123 ;PMID: 20879881 ;CODEN: NEJMAG

Full text available

18
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
Material Type:
Article
Add to My Research

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial

The lancet oncology, 2017-06, Vol.18 (6), p.732-742 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 1, 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30312-1 ;PMID: 28526536

Full text available

19
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
Material Type:
Article
Add to My Research

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Annals of oncology, 2018-05, Vol.29 (5), p.1180-1188 [Peer Reviewed Journal]

2018 THE AUTHORS ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy058 ;PMID: 29432521

Full text available

20
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Material Type:
Article
Add to My Research

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

The New England journal of medicine, 2019-12, Vol.381 (25), p.2391-2402 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1910962 ;PMID: 31562799

Full text available

Results 1 - 20 of 533,834  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (483,187)

Refine My Results

Creation Date 

From To
  1. Before 1958  (355)
  2. 1958 To 1974  (4,035)
  3. 1975 To 1991  (28,180)
  4. 1992 To 2009  (169,810)
  5. After 2009  (331,287)
  6. More options open sub menu

Subject 

  1. Science & Technology  (441,270)
  2. Life Sciences & Biomedicine  (404,888)
  3. Humans  (332,347)
  4. Female  (215,502)
  5. Male  (196,637)
  6. Middle Aged  (151,871)
  7. Survival  (129,996)
  8. Aged  (129,461)
  9. Oncology  (123,945)
  10. Survival Analysis  (120,275)
  11. Adult  (115,726)
  12. Animals  (115,065)
  13. Biological And Medical Sciences  (106,730)
  14. Prognosis  (98,424)
  15. Survival Rate  (93,272)
  16. Medical Sciences  (89,118)
  17. Cell Survival  (70,080)
  18. Retrospective Studies  (69,272)
  19. Treatment Outcome  (66,993)
  20. Surgery  (66,182)
  21. More options open sub menu

Language 

  1. English  (522,952)
  2. Japanese  (81,084)
  3. German  (3,342)
  4. Portuguese  (3,037)
  5. Spanish  (2,712)
  6. French  (2,166)
  7. Chinese  (1,227)
  8. Korean  (798)
  9. Russian  (774)
  10. Norwegian  (549)
  11. Persian  (360)
  12. Turkish  (323)
  13. Polish  (250)
  14. Italian  (201)
  15. Swedish  (142)
  16. Czech  (132)
  17. Ukrainian  (105)
  18. Croatian  (91)
  19. Romanian  (89)
  20. Serbian  (84)
  21. More options open sub menu

Searching Remote Databases, Please Wait